series-c-plus
Stage
1
Investors
About
Exelixis is a biotechnology company focused on discovering, developing, and commercializing therapies for cancer treatment, specializing in small molecules and biotherapeutics targeting various cancer types.
Explore Exelixis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.